Efficacy of Avapritinib in Patients with Advanced Systemic Mastocytosis: Hematologic and Bone Marrow Responses from the Phase 2 Open-Label, Single-Arm, Pathfinder Study
Year: 2021
Type: conference-abstract
Source: Blood
Institutions: University of Utah, ARUP Laboratories (United States), Blueprint Medicines (United States), Heidelberg University, University Medical Centre Mannheim, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, Huntsman Cancer Institute, Stanford Medicine, Stanford Cancer Institute, Stanford University, Dana-Farber Cancer Institute
Language: English
Topic: Mast cells and histamine
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3213299519
